HIV & AIDS
Tuberculosis
Malaria
The Global Fund / Nana Kofi Acquah
OverviewRSS
We bring together news, announcements and other updates from around Global Fund in this section. You can receive a notification every time a new update is published by using our really simple syndication (RSS) feed. See our RSS Feeds page for more information.
-
Sourcing & Management of Health Products
COVID-19 Procurement and Supply Update for Global Fund Principal Recipients
The Global Fund continues to work closely with our technical partners, especially the Stop TB Partnership's Global Drug Facility and our procurement service agents, as the global response to the COVID-19 pandemic evolves.
Read more -
Updates
Data Explorer: Historic Grant Documents
The Global Fund Data Explorer now features documents related to closed grants. Navigate to a specific grant to see, when available, historic grant agreements, implementation letters, grant performance reports, grand score cards, notification letters and more.
Read more -
Office of the Inspector General
Global Fund Recoveries Management Processes
Read more -
Sourcing & Management of Health Products
COVID-19 Impact on Supply Chain Logistics: Assessment and Recommendations
The global response to control the outbreak of the new coronavirus, COVID-19, may influence health product supply chains, including logistics and shipping, as almost all finished health products or ingredients used in health products originate from China.
Read more -
Sourcing & Management of Health Products
Opportunity for Evaluation of Selected Medicines
The Global Fund, Stop TB Partnership Global Drug Facility and Unitaid are inviting manufacturers of antiretroviral (HIV/AIDS), antihepatitis B and C, antituberculosis and antimalarial medicines to submit an expression of interest to have their products evaluated by the Expert Review Panel for Pharmaceutical Products.
Read more -
News
Global Fund Issues New Guidance in Response to COVID-19
The Global Fund announced today new guidance to enable countries to strengthen their response to the new coronavirus, COVID-19, by using existing grants in a swift, nimble and pragmatic way.
Read more